I expect some pull back since OPK has gone up 20% + in the past week . The 12 month target high estimate os analyst is $8.50 and the lowest is $3.00 .OPK has been working on reducing overspending and improving BioReference and returning to profitability. Overall is still a good stock to own for 2023 - 2024.IMO